Table 1

Clinical characteristics of aSAH patients with preventive and rescue intrathecal therapy

PREVENTIVERESCUEP value
No of patients, n (%)62 (73.8)22 (26.1)
Type of intervention for cisternal therapy
 STX-VCS, n (%)51 (82)22 (100)
 CVC, n (%)11 (18)
Time between aSAH onset and intervention, mean, hours (range)53 (4–108)161 (24–272) <0.0001
Female, number (%)43 (69%)17 (77)0.59
Age, median, years (IQR)61 (52–66)52 (45–63) 0.033
WFNS grade, n (%)
 12 (3)7 (32) <0.0001
 24 (6)3 (14)
 34 (6)4 (18)
 412 (19)1 (5)
 543 (69)7 (32)
Hijdra score
 Ventricles6.2 (4.1)3.3 (4.3) 0.0049
 Cisterns20.1 (8.0)13.1 (7.2) 0.0003
 Total26.3 (8.6)16.5 (7.3) 0.0001
Location of ruptured aneurysm, n (%)
 MCA13 (21)11 (50) 0.0055
 ACA34 (55)3 (14)
 ICA7 (11)5 (23)
 PCA8 (13)3 (14)
Aneurysm treatment, n (%)
 Clip24 (38)14 (64)0.051
 Coil38 (62)8 (36)
Prespecified DCI-risk by de Rooij score, % (SD)47.5% (±11.4)37.7% (±15.1) 0.003
  • p-values of parameters reaching statistically significant differences between groups are marked in bold font

  • ACA, anterior cerebral artery; aSAH, aneurysmal subarachnoid haemorrhage; CVC, cisterno-ventriculostomy catheter; DCI, delayed cerebral infarction; ICA, internal carotid artery; MCA, middle cerebral artery; PCA, posterior circulation arteries; STX-VCS, stereotactic catheter ventriculocisternostomy; WFNS, World Federation of Neurosurgical Societies.